Skip to main content
Clinical Trials/CTRI/2024/07/071211
CTRI/2024/07/071211Not yet recruitingPhase 4

Comparison of The Effect of Etonogestrel Subdermal Single Rod Implant and Depot Medroxyprogesterone Acetate on Menstrual Pattern: A Randomized Controlled Trial - NI

isha R0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 4
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1.Willing to participate in the study and for follow up at 3 months.
  • 2. Age group of 18-40 years
  • 3. Desire a highly effective temporary method of contraception

Exclusion Criteria

  • 1.Undiagnosed genital bleeding
  • 2.Less than 6 weeks postpartum
  • 3.Active thrombophlebitis or thromboembolic disease
  • 4. Acute liver disease, benign or malignant liver tumors
  • 5. Known or suspected breast cancer
  • 6.Women with known case of depression or other mental Health disorder
  • 7.On drugs induced by liver enzymes or drugs that interfere with coagulation
  • 8.Severe cardiovascular disease
  • 9.Severe hirsutism
  • 10.Any skin infection at the local site of the proposed injection

Investigators

Sponsor
isha R

Similar Trials

Completed
Not Applicable
Comparison of two protocol of endometrial preparation in thawed- embryo transfer cyclesInfertility.Complication associated with artificial fertilization, unspecified
IRCT2012071910328N2Wise Canceler of Shahid Sadoughi University of Medical Sciences of Yazd,Research and Clinical Cente90
Completed
Not Applicable
The effect of subcutaneous and intracutaneous injection of distilled sterilized water and normal saline on the severity of childbirth paiStudy of the effect of injection distilled sterilized water and normal saline on the severity of labor pain.Pain, unspecified
IRCT20180128038535N1Jahrom University of Medical Sciences164
Active, not recruiting
Not Applicable
Efficacy and Tolerability of Subcutaneous Progesterone (IBSA) versus Vaginal Progesterone Gel (Crinone) for Luteal Phase Support in Patients Undergoing In-Vitro Fertilization (IVF).uteal phase support in patients undergoing Assisted Reproductive Technology (IVF).MedDRA version: 14.1Level: PTClassification code 10021926Term: InfertilitySystem Organ Class: 10038604 - Reproductive system and breast disorders
EUCTR2007-006595-11-ITIBSA672
Active, not recruiting
Phase 1
Efficacy and Tolerability of Subcutaneous Progesterone (IBSA) versus Vaginal Progesterone Gel (Crinone) for Luteal Phase Support in Patients Undergoing In-Vitro Fertilization (IVF).Patients undergoing in-Vitro Fertilization (IVF)MedDRA version: 9.1 Level: LLT Classification code 10021572 Term: In vitro fertilization
EUCTR2007-006595-11-GBIBSA Institut Biochimique SA
Active, not recruiting
Not Applicable
Efficacy and Tolerability of Subcutaneous Progesterone (IBSA)versus Vaginal Progesterone Gel (Crinone®) for Luteal Phase Supportin Patients Undergoing In-Vitro Fertilization (IVF).Patient undergoing in-Vitro Fertlization (IVF)MedDRA version: 9.1Level: LLTClassification code 10021572Term: In vitro fertilization
EUCTR2007-006595-11-HUIBSA Institute Biochimique SA672